[ASAP] NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00668

Source: Molecular Pharmaceutics - December 9, 2022 Category: Drugs & Pharmacology Authors: Elke Lipka, Aaron M. Chadderdon, Cheryl C. Harteg, Matthew K. Doherty, Eric S. Simon, John M. Domagala, Dawn M. Reyna, Kim M. Hutchings, Xinmin Gan, Andrew D. White, Caroll B. Hartline, Emma A. Harden, Kathy A. Keith, Mark N. Prichard ⧫, Scott H. James, Source Type: research